BIONOVO INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY11 | FY10 | FY09 | |
|---|---|---|---|
| Revenue | $2.1M | $613,000 | $288,000 |
| Operating income | −$99.3M | −$17.6M | −$16.3M |
| Net income | −$87.2M | −$17.7M | −$16.4M |
| Total assets | $18.5M | $13.0M | — |
| Total liabilities | $7.5M | $6.4M | — |
| Equity | $11.0M | $6.6M | $21.9M |
| EPS (diluted) | — | — | — |
| Shares out. | 54.6M | 24.5M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2011- Operating margin
- −4824.0%
- Net margin
- −4239.3%
- Return on equity
- −792.9%
- Return on assets
- −472.7%
- Return on capital (ROCE)
- −893.0%
- Liabilities / assets
- 40.4%
- Debt / equity
- 0.68×
- Book value / share
- $0.20
- Revenue growth (YoY)
- 235.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2011- Accruals / assets
- −52.1%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 3 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 16, 2005
- NT 10-Qmissed a reporting deadline ↗May 16, 2005
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2003
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivershipNov 1, 2012
- Other material eventMay 25, 2012
- Director / officer change · Shareholder voteMay 8, 2012
- Director / officer changeApr 27, 2012
- Entered a material agreement · Other material eventMar 12, 2012
- Other material eventMar 12, 2012
- Terminated a material agreementMar 1, 2012
- Other material eventMar 1, 2012
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- REVOKEDFeb 21, 2017
- SC 13G/ABIONOVO INC SC13GAFeb 6, 2013
- SC 13G/ABIONOVO, INC.Jan 22, 2013
- 8-KNov 1, 2012
- 8-K/AFORM 8-K/AMay 29, 2012
- 8-KMay 25, 2012
- 10-QMay 15, 2012
- 8-KFORM 8-KMay 8, 2012
- 8-KApr 27, 2012
- UPLOADApr 4, 2012
- DEF 14AApr 3, 2012
- PRER14AApr 3, 2012
- UPLOADApr 2, 2012
- 10-KMar 30, 2012
- PRE 14AFORM PRE 14AMar 27, 2012
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.